↓ Skip to main content

Natalizumab in the treatment of multiple sclerosis

Overview of attention for article published in Therapeutics and Clinical Risk Management, July 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

patent
5 patents

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
24 Mendeley